› Infectious Diseases

Infectious Diseases

The world is facing an alarming increase in drug resistant micro-organisms, global spread of infectious diseases and the threat of bio-terrorism. Developing antimicrobial agents is complex and expensive. This field is constantly changing with the re-emergence of polio, cholera and tuberculosis – and the appearance of new threats, including SARS, H1N1, and HIV.

Given these realities, Onorach are active in clinical trials of new and improved vaccines to prevent disease and new antimicrobial agents with improved efficacy and safety, delivered in a timely and cost-effective manner.

Through our team's experience in infectious disease trials in this therapeutic area, we have been able to deliver:

Rapid enrolment during peak illness seasons
Large patient recruitment in both developed and developing regions
Monitoring complex studies of long duration
Ensuring global regulatory requirements are met

Client Testimonial

Prof. Leiper and her team at Onorach have demonstrated competencies in many areas in both working with the authorities and with the sites as monitors. They impressed us deeply with highly motivated, goal-oriented staff members of lively personality and creativity. It was always a pleasure to cooperate with Onorach Clinical.

A German Client